Tumor Necrosis Factor Alpha-Mediated Interaction Between Microglia and Müller Cells Exacerbates Retinal Ganglion Cell

Shu-Ying Li1, Hong Zhou1, Guoli Zhao1,2

  • 1State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, 200032, China.

Neuroscience Bulletin
|August 30, 2025
PubMed

Insights

Tumor necrosis factor-alpha (TNF-α) from microglia drives Müller cell activation and chemokine C-C motif ligand 2 (CCL2) release. This exacerbates neuroinflammation and retinal ganglion cell (RGC) death in glaucoma.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Immunology

Background:

  • Glaucoma involves neuroinflammation and retinal ganglion cell (RGC) death.
  • Müller cells and microglia interactions worsen RGC injury.

Purpose of the Study:

  • Investigate tumor necrosis factor-alpha (TNF-α) role in Müller cell-microglia crosstalk.
  • Determine TNF-α's impact on RGC injury in a chronic ocular hypertension (COH) glaucoma model.

Main Methods:

  • Utilized a chronic ocular hypertension (COH) glaucoma model.
  • Performed in vivo and in vitro co-culture experiments.
  • Analyzed Müller cell and microglial activation, migration, and proliferation.
  • Investigated chemokine C-C motif ligand 2 (CCL2) involvement via knockdown.

Main Results:

  • Elevated TNF-α in COH retinas activated Müller cells and microglia, recruiting microglia.
  • Müller cells enhanced TNF-α-induced microglial activation, migration, and proliferation.
  • CCL2, released by Müller cells, mediated TNF-α effects on microglia.
  • CCL2 knockdown attenuated RGC damage and vision loss.

Conclusions:

  • Microglial TNF-α induces Müller cell CCL2 secretion.
  • This crosstalk exacerbates neuroinflammation and RGC injury in glaucoma.
  • Targeting the TNF-α/CCL2 pathway may offer therapeutic benefits for glaucoma.